Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications
Complex Psychiatry · 2016 · 2 (1) · 1-14
DOI: 10.1159/000441521 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Complex Psychiatry, online erschienen am 08.01.2016. Verfasst von Trehani M Fonseka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University Health Network, University of Toronto, Toronto, Ont., Canada; Department of Psychiatry, St. Michael's Hospital, …. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Antipsychotic medications (APs), particularly second-generation APs, are associated with significant weight gain in schizophrenia patients. Recent evidence suggests that the immune system may contribute to antipsychotic-induced weight gain (AIWG) via AP-mediated alterations of cytokine levels. Antipsychotics with a high propensity for weight gain, such as clozapine and olanzapine, influence the expression of immune genes, and induce changes in serum cytokine levels to ultimately down-regulate neuroinflammation. Since inflammatory cytokines are normally involved in anorexigenic responses, reduced inflammation has been independently shown to mediate changes in feeding behaviours and other metabolic parameters, resulting in obesity. Genetic variation in pro-inflammatory cytokines is also associated with both general obesity and weight change during AP treatment, and thus, may be implicated in the pharmacogenetics of AIWG. At this time, preliminary data support a cytokine-mediated model of AIWG which may have clinical utility in developing more effective metabolic monitoring guidelines and prevention measures. However, further research is still needed to clearly elucidate the validity of this immune model. This article reviews the evidence implicating inflammatory cytokines in AIWG and its potential clinical relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, University Health Network, University of Toronto, Toronto, Ont., Canada; Department of Psychiatry, St. Michael's Hospital, University of Toronto, Toronto, Ont., Canada; Pharmacogenetics Researc…
- Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ont., Canada.
- Department of Psychiatry, University Health Network, University of Toronto, Toronto, Ont., Canada; Department of Psychiatry, St. Michael's Hospital, University of Toronto, Toronto, Ont., Canada.
Zitieren
APA
Fonseka, T. M., Müller, D. J., & Kennedy, S. H. (2016). Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications. Complex Psychiatry, 2(1), 1-14. https://doi.org/10.1159/000441521
Vancouver
Fonseka TM, Müller DJ, Kennedy SH. Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications. Complex Psychiatry. 2016;2(1):1-14. doi:10.1159/000441521
BibTeX
@article{Fonseka2016,
author = {Fonseka, Trehani M and Müller, Daniel J and Kennedy, Sidney H},
title = {Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications},
journal = {Complex Psychiatry},
year = {2016},
volume = {2},
number = {1},
pages = {1--14},
doi = {10.1159/000441521}
}
EUVIMED